Literature DB >> 28629271

Expression of Interleukin-1 and temporomandibular disorder: Contemporary review of the literature.

Adam Sorenson1, Kyle Hresko1, Seth Butcher1, Sean Pierce2, Vinicius Tramontina3, Rosalia Leonardi4, Carla Loreto5, Jose Bosio6, Luis Eduardo Almeida1.   

Abstract

OBJECTIVE: Temporomandibular disorders (TMD) are a group of conditions affecting the temporomandibular joint (TMJ), leading to jaw dysfunction, joint and muscle pain, and a decrease in quality of life. A communication network of pro- and anti-inflammatory mediators called cytokines maintains the homeostasis of the TMJ. This review will focus on the Interleukin (IL) family of cytokines, which have been quantified in TMJ synovial fluids in a variety of studies. IL-1α and IL-1β have pro-inflammatory effects, while the endogenous receptor antagonist (IL-1RA) inhibits the pro-inflammatory effects of IL-1.
METHODS: A literature search (2006-2016) to identify eligible studies was completed using the PubMed database. Studies identified used saline irrigation to quantify cytokine profiles in synovial fluid of healthy and/or dysfunctional joints.
RESULTS: The initial search yielded 111 articles, 5 of which met the inclusion criteria after inter-reviewer discussion.
CONCLUSIONS: Articles that compared IL-1 concentrations in TMD vs. control groups found significant differences.

Entities:  

Keywords:  Interleukin-1; Temporomandibular joint; temporomandibular joint disorder

Mesh:

Substances:

Year:  2017        PMID: 28629271     DOI: 10.1080/08869634.2017.1342890

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  7 in total

1.  Effects of interleukin 1β on long noncoding RNA and mRNA expression profiles of human synovial fluid derived mesenchymal stem cells.

Authors:  Yang-Peng Sun; Yun-Yang Lu; Jianyu Chen; Jia-Hao Bao; Hong Zhang; Jia-Dong Sun; Wen-Ting Liao
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

Review 2.  Biomarkers for Temporomandibular Disorders: Current Status and Future Directions.

Authors:  Abdalwhab Zwiri; Mohammad A I Al-Hatamleh; Wan Muhamad Amir W Ahmad; Jawaad Ahmed Asif; Suan Phaik Khoo; Adam Husein; Zuryati Ab-Ghani; Nur Karyatee Kassim
Journal:  Diagnostics (Basel)       Date:  2020-05-15

3.  BRD4 inhibition alleviates mechanical stress-induced TMJ OA-like pathological changes and attenuates TREM1-mediated inflammatory response.

Authors:  Ziwei Huang; Ren Yang; Lu Zhang; Mengjiao Zhu; Caixia Zhang; Juan Wen; Huang Li
Journal:  Clin Epigenetics       Date:  2021-01-15       Impact factor: 6.551

Review 4.  An Update on Mesenchymal Stem Cell-Centered Therapies in Temporomandibular Joint Osteoarthritis.

Authors:  Yifan Zhao; Liang Xie
Journal:  Stem Cells Int       Date:  2021-04-01       Impact factor: 5.443

5.  Histone deacetylase inhibitors attenuated interleukin-1β-induced chondrogenesis inhibition in synovium-derived mesenchymal stem cells of the temporomandibular joint.

Authors:  Wen-Ting Liao; Jia-Dong Sun; Yun Wang; Yi-Qing He; Kai Su; Yun-Yang Lu; Guiqing Liao; Yang-Peng Sun
Journal:  Bone Joint Res       Date:  2022-01       Impact factor: 5.853

6.  Rapamycin-Induced Autophagy Promotes the Chondrogenic Differentiation of Synovium-Derived Mesenchymal Stem Cells in the Temporomandibular Joint in Response to IL-1β.

Authors:  Wenjing Liu; Haiyun Luo; Ruolan Wang; Yiyuan Kang; Wenting Liao; Yangpeng Sun; Guodong Chen; Longquan Shao
Journal:  Biomed Res Int       Date:  2020-10-22       Impact factor: 3.411

Review 7.  A comprehensive review on biomarkers associated with painful temporomandibular disorders.

Authors:  Mayank Shrivastava; Ricardo Battaglino; Liang Ye
Journal:  Int J Oral Sci       Date:  2021-07-29       Impact factor: 6.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.